Your browser doesn't support javascript.
loading
Novel oral transforming growth factor-ß signaling inhibitor EW-7197 eradicates CML-initiating cells.
Naka, Kazuhito; Ishihara, Kaori; Jomen, Yoshie; Jin, Cheng Hua; Kim, Dong-Hyun; Gu, Yoon-Kang; Jeong, Eun-Sook; Li, Shaoguang; Krause, Daniela S; Kim, Dong-Wook; Bae, Eunjin; Takihara, Yoshihiro; Hirao, Atsushi; Oshima, Hiroko; Oshima, Masanobu; Ooshima, Akira; Sheen, Yhun Yhong; Kim, Seong-Jin; Kim, Dae-Kee.
Afiliação
  • Naka K; Exploratory Project on Cancer Stem Cells, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
  • Ishihara K; Department of Stem Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Jomen Y; Exploratory Project on Cancer Stem Cells, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
  • Jin CH; Exploratory Project on Cancer Stem Cells, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
  • Kim DH; Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul, Korea.
  • Gu YK; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Korea.
  • Jeong ES; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Korea.
  • Li S; Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Korea.
  • Krause DS; Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
  • Kim DW; Institute for Tumor Biology and Experimental Therapy, Georg Speyer Haus, Goethe University, Frankfurt, Germany.
  • Bae E; Department of Hematology, Seoul St. Mary's Hospital, Cancer Research Institute, The Catholic University of Korea, Seoul, Korea.
  • Takihara Y; Exploratory Project on Cancer Stem Cells, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
  • Hirao A; CHA Cancer Institute and Department of Biomedical Science, CHA University, Seongnam, Korea.
  • Oshima H; Department of Stem Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Oshima M; Division of Molecular Genetics, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
  • Ooshima A; Division of Genetics, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
  • Sheen YY; Division of Genetics, Cancer Research Institute, Kanazawa University, Kanazawa, Japan.
  • Kim SJ; CHA Cancer Institute and Department of Biomedical Science, CHA University, Seongnam, Korea.
  • Kim DK; College of Pharmacy, Ewha Womans University, Seoul, Korea.
Cancer Sci ; 107(2): 140-8, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26583567
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Triazóis / Leucemia Mielogênica Crônica BCR-ABL Positiva / Protocolos de Quimioterapia Combinada Antineoplásica / Compostos de Anilina Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cancer Sci Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Triazóis / Leucemia Mielogênica Crônica BCR-ABL Positiva / Protocolos de Quimioterapia Combinada Antineoplásica / Compostos de Anilina Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cancer Sci Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Japão